Home/Vesper Medical/Mike Longo

ML

Mike Longo

VP of Research and Development

Therapeutic Areas

Chronic Venous Insufficiency Vascular Disease

Vesper Medical Pipeline

Drug	Indication	Phase
Vesper DUO Venous Stent System	Symptomatic Chronic Venous Insufficiency (CVI) due to iliac and/or common femoral vein obstruction	Phase 3

Leadership Team at Vesper Medical

President and CEO

Mark J. Garcia, MD

Chief Medical Officer

Joseph C. Griffin, III

VP, Regulatory Affairs and QA, Compliance Officer

VP, Clinical Affairs

View full Vesper Medical profile